🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to evaluate the effects on exercise duration...
Status
Completed
Location
205.368.01023 Boehringer Ingelheim Investigational Site
Start Date
2007-08
Trial ID
NCT00525512
Treatments Being Tested
The study compared the 24-hour spirometry profile of indacaterol with that ...
Status
Completed
Location
Novartis Investigative site
Start Date
2008-02
Trial ID
NCT00615459
Treatments Being Tested
This is a Phase IIIb multicentre, randomised, blinded, triple dummy, parall...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-10-15
Trial ID
NCT02257385
The study will assess if regular use of tiotropium (i.e. daily) results in ...
Status
Completed
Location
Asthma Research Lab University of Saskatchewan Room 346 Ellis Hall
Start Date
2021-12-13
Trial ID
NCT05113615
Treatments Being Tested
To demonstrate that tiotropium (Spiriva®) does not prolong the QT interval ...
Status
Completed
Location
Humanpharmakologisches Zentrum
Start Date
2004-10
Trial ID
NCT00257452
Treatments Being Tested
The overall objective of this study is to assess efficacy and safety of 12 ...
Status
Completed
Location
1222.52.02090 Boehringer Ingelheim Investigational Site
Start Date
2012-09
Trial ID
NCT01696058
Treatments Being Tested
The primary objective of this trial is to investigate the effect of 6 weeks...
Status
Completed
Location
1237.13.01302 Boehringer Ingelheim Investigational Site
Start Date
2012-03
Trial ID
NCT01533922
Treatments Being Tested
The primary objective of this trial is to evaluate the safety and efficacy ...
Status
Completed
Location
205.443.12003 Boehringer Ingelheim Investigational Site
Start Date
2012-07
Trial ID
NCT01634113
Treatments Being Tested
The purpose of this study is to evaluate discontinuation rates of roflumila...
Status
Completed
Location
Multiple Locations
Start Date
2014-05-01
Trial ID
NCT02165826
Treatments Being Tested
The overall objective of this study is to assess efficacy and safety of 12 ...
Status
Completed
Location
1222.51.01055 Boehringer Ingelheim Investigational Site
Start Date
2012-09
Trial ID
NCT01694771
Treatments Being Tested